[HTML][HTML] Immune determinants of COVID-19 disease presentation and severity

P Brodin - Nature medicine, 2021 - nature.com
… infection is not the only outcome of COVID-19, and long-… disease, chronic obstructive
pulmonary disease and cardiovascular disease are all associated with severe COVID-19 disease 2 …

[HTML][HTML] Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta …

P Paliogiannis, AA Mangoni, M Cangemi… - Clinical and …, 2021 - Springer
… albumin concentrations and COVID-19 disease severity and adverse outcomes. A systematic
… studies in 19,760 COVID-19 patients (6141 with severe disease or poor outcome) were …

Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers

Y Tjendra, AF Al Mana, AP Espejo… - … of pathology & …, 2020 - meridian.allenpress.com
Context.— An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

[HTML][HTML] Sex differences in immune responses that underlie COVID-19 disease outcomes

T Takahashi, MK Ellingson, P Wong, B Israelow… - Nature, 2020 - nature.com
… for further investigation into how COVID-19 disease dynamics may differ between male and
… early during disease. The immune landscape in patients with COVID-19 is considerably …

[HTML][HTML] Determinants of COVID-19 disease severity in patients with cancer

EV Robilotti, NE Babady, PA Mead, T Rolling… - Nature medicine, 2020 - nature.com
… Further, we describe outcomes on COVID-19-associated respiratory compromise and …
reporting primary study outcomes and death rates. In summary, the outcome of COVID-19 is worse …

[HTML][HTML] Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning

C Sun, S Hong, M Song, H Li, Z Wang - BMC Medical Informatics and …, 2021 - Springer
… Specifically, our method predicted the outcome of COVID-19 patients by considering both
the … units, to subtype the patient stages and describe the disease progression of COVID-19. …

Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study

G Rojas-Marte, M Khalid, O Mukhtar… - … Journal of Medicine, 2020 - academic.oup.com
… in patients with severe to critical COVID-19 disease who received tocilizumab. When intubated
… We retrospectively analyzed the outcomes of severe COVID-19 disease among patients …

Estimates of the severity of COVID-19 disease

R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker… - MedRxiv, 2020 - medrxiv.org
outcome. Finally, as clinical knowledge of this new disease accrues, it is possible that
outcomes will improve. It will therefore be important to revise these estimates as epidemics unfold. …

Biomarkers associated with COVID-19 disease progression

G Ponti, M Maccaferri, C Ruini, A Tomasi… - Critical reviews in …, 2020 - Taylor & Francis
… Binary logistic analysis identified elevated NLR (hazard risk (HR): 2.46, 95% confidence
interval (CI): 1.98–4.57) as an independent factor for poor COVID-19 clinical outcome [Citation…

[HTML][HTML] Collider bias undermines our understanding of COVID-19 disease risk and severity

GJ Griffith, TT Morris, MJ Tudball, A Herbert… - Nature …, 2020 - nature.com
… Numerous observational studies have attempted to identify risk factors for infection with
SARS-CoV-2 and COVID-19 disease outcomes. Studies have used datasets sampled from …